IE57094B1 - 1-(2-carbethoxy 4-benzalkylamido phenoxy)3-amino 2-propanols,preparation thereof and use thereof in therapeutics - Google Patents
1-(2-carbethoxy 4-benzalkylamido phenoxy)3-amino 2-propanols,preparation thereof and use thereof in therapeuticsInfo
- Publication number
- IE57094B1 IE57094B1 IE528/84A IE52884A IE57094B1 IE 57094 B1 IE57094 B1 IE 57094B1 IE 528/84 A IE528/84 A IE 528/84A IE 52884 A IE52884 A IE 52884A IE 57094 B1 IE57094 B1 IE 57094B1
- Authority
- IE
- Ireland
- Prior art keywords
- benzamido
- carbethoxy
- phenoxy
- formula
- propanol
- Prior art date
Links
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 title claims description 54
- 239000003814 drug Substances 0.000 title description 4
- 238000002360 preparation method Methods 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 125000004429 atom Chemical group 0.000 claims abstract description 8
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 150000002367 halogens Chemical class 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 4
- 239000001257 hydrogen Substances 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 128
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 25
- -1 alkoxy radical Chemical class 0.000 claims description 13
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical group O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- VKWYVLFXVFYGJM-UHFFFAOYSA-N 1-iminopropan-2-ol Chemical compound CC(O)C=N VKWYVLFXVFYGJM-UHFFFAOYSA-N 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 5
- 150000001298 alcohols Chemical class 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229960004592 isopropanol Drugs 0.000 description 42
- 230000008018 melting Effects 0.000 description 31
- 238000002844 melting Methods 0.000 description 31
- 239000013078 crystal Substances 0.000 description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 229910052731 fluorine Inorganic materials 0.000 description 12
- 239000011737 fluorine Substances 0.000 description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 150000002118 epoxides Chemical class 0.000 description 8
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 8
- 229940011051 isopropyl acetate Drugs 0.000 description 8
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- RNFDZDMIFOFNMC-UHFFFAOYSA-N 1-(propan-2-ylamino)propan-2-ol Chemical compound CC(C)NCC(C)O RNFDZDMIFOFNMC-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 description 6
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 6
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 6
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- UJUKHOATWVVDER-UHFFFAOYSA-N 1-amino-1-phenoxypropan-1-ol Chemical compound CCC(N)(O)OC1=CC=CC=C1 UJUKHOATWVVDER-UHFFFAOYSA-N 0.000 description 1
- BIEXWTLSOKJVPK-UHFFFAOYSA-N 4-fluoro-n-(4-hydroxyphenyl)benzamide Chemical compound C1=CC(O)=CC=C1NC(=O)C1=CC=C(F)C=C1 BIEXWTLSOKJVPK-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- SJLBBSDNKAPLHG-UHFFFAOYSA-N C1=C(O)C(C(=O)OCC)=CC(NC(=O)C=2C(=CC=CC=2)F)=C1 Chemical compound C1=C(O)C(C(=O)OCC)=CC(NC(=O)C=2C(=CC=CC=2)F)=C1 SJLBBSDNKAPLHG-UHFFFAOYSA-N 0.000 description 1
- HNUALPPJLMYHDK-UHFFFAOYSA-N C[CH]C Chemical compound C[CH]C HNUALPPJLMYHDK-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical class CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- YMMCVTLWLBSENY-UHFFFAOYSA-N ethyl 2-hydroxy-5-[(2-methylbenzoyl)amino]benzoate Chemical compound C1=C(O)C(C(=O)OCC)=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 YMMCVTLWLBSENY-UHFFFAOYSA-N 0.000 description 1
- SBFDMSNQNXCESC-UHFFFAOYSA-N ethyl 2-hydroxy-5-[(3-methoxybenzoyl)amino]benzoate Chemical compound C1=C(O)C(C(=O)OCC)=CC(NC(=O)C=2C=C(OC)C=CC=2)=C1 SBFDMSNQNXCESC-UHFFFAOYSA-N 0.000 description 1
- FHGLPYAUTNUECU-UHFFFAOYSA-N ethyl 5-[(3-chlorobenzoyl)amino]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OCC)=CC(NC(=O)C=2C=C(Cl)C=CC=2)=C1 FHGLPYAUTNUECU-UHFFFAOYSA-N 0.000 description 1
- SNLZUAODDRXKCM-UHFFFAOYSA-N ethyl 5-[(4-chlorobenzoyl)amino]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OCC)=CC(NC(=O)C=2C=CC(Cl)=CC=2)=C1 SNLZUAODDRXKCM-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- ATADHKWKHYVBTJ-UHFFFAOYSA-N hydron;4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;chloride Chemical compound Cl.CNCC(O)C1=CC=C(O)C(O)=C1 ATADHKWKHYVBTJ-UHFFFAOYSA-N 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000006263 metalation reaction Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- FIPXHELNPLCOPK-UHFFFAOYSA-N n-(4-hydroxyphenyl)-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=CC=C(O)C=C1 FIPXHELNPLCOPK-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8304150A FR2542737B1 (fr) | 1983-03-14 | 1983-03-14 | Nouveaux (carbethoxy-2 benzalkylamido-4 phenoxy)-1 amino-3 propanols-2, leurs preparations et leurs utilisations en therapeutique |
| FR8318509A FR2555169B2 (fr) | 1983-11-21 | 1983-11-21 | Nouveaux (carbethoxy-2 benzalkylamido-4 phenoxyl)-1 amino-3 propanols-2, leurs preparations et leurs utilisations en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE840528L IE840528L (en) | 1984-09-14 |
| IE57094B1 true IE57094B1 (en) | 1992-04-22 |
Family
ID=26223333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE528/84A IE57094B1 (en) | 1983-03-14 | 1984-03-05 | 1-(2-carbethoxy 4-benzalkylamido phenoxy)3-amino 2-propanols,preparation thereof and use thereof in therapeutics |
Country Status (12)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0617020A1 (en) * | 1992-04-02 | 1994-09-28 | Shudo, Koichi, Prof. Dr. | Carboxylic acid derivatives having retinoic acid-like activity |
| DE60013491T2 (de) * | 2000-04-19 | 2005-09-01 | Neurotech Co., Ltd., Suwon | Verbindungen, zusammensetzungen und verfahren zur vorbeugung der neurodegeneration bei akuten oder chronischen verletzungen des zentralen nervensystems |
| US6964982B2 (en) | 2000-04-20 | 2005-11-15 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| CA2490120C (en) | 2002-06-19 | 2010-06-01 | Neurotech Co., Ltd. | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| AU2007239191B2 (en) | 2006-04-13 | 2010-10-28 | Neurotech Pharmaceuticals Co., Ltd. | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| KR100852962B1 (ko) | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
| CN101903166B (zh) | 2007-12-14 | 2013-07-24 | 3M创新有限公司 | 纤维聚集体 |
| MX2010006456A (es) | 2007-12-14 | 2010-09-28 | Schlumberger Technology Bv | Materiales de consolidacion y usos de los mismos. |
| EA021092B1 (ru) | 2007-12-14 | 2015-04-30 | Шлюмбергер Текнолоджи Б.В. | Способ обработки подземных скважин с использованием изменяемых добавок |
| KR101204108B1 (ko) * | 2009-02-09 | 2012-11-22 | 주식회사 지엔티파마 | 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3852468A (en) * | 1967-02-27 | 1974-12-03 | Ici Ltd | Alkanolamine derivatives as {62 -adrenergic blocking agents |
| MX158644A (es) * | 1982-07-20 | 1989-02-21 | Menarini Sas | Procedimiento para preparar un derivado 1-alquilamina-3-(4(p-alquiloxibenzamida)-fenoxi)-2propanol |
-
1984
- 1984-02-28 DK DK117484A patent/DK117484A/da not_active Application Discontinuation
- 1984-03-05 IE IE528/84A patent/IE57094B1/en unknown
- 1984-03-12 AT AT84400490T patent/ATE20879T1/de active
- 1984-03-12 EP EP84400490A patent/EP0122827B1/fr not_active Expired
- 1984-03-12 DE DE8484400490T patent/DE3460323D1/de not_active Expired
- 1984-03-12 PT PT78238A patent/PT78238B/pt not_active IP Right Cessation
- 1984-03-12 GR GR74075A patent/GR81821B/el unknown
- 1984-03-12 ES ES530503A patent/ES8504681A1/es not_active Expired
- 1984-03-13 AU AU25537/84A patent/AU567332B2/en not_active Ceased
- 1984-03-13 KR KR1019840001323A patent/KR910002945B1/ko not_active Expired
- 1984-03-13 CA CA000449516A patent/CA1218378A/en not_active Expired
- 1984-03-14 PH PH30393A patent/PH19184A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES530503A0 (es) | 1985-05-01 |
| IE840528L (en) | 1984-09-14 |
| DE3460323D1 (en) | 1986-08-28 |
| CA1218378A (en) | 1987-02-24 |
| DK117484D0 (da) | 1984-02-28 |
| EP0122827B1 (fr) | 1986-07-23 |
| ES8504681A1 (es) | 1985-05-01 |
| EP0122827A1 (fr) | 1984-10-24 |
| AU567332B2 (en) | 1987-11-19 |
| AU2553784A (en) | 1984-09-20 |
| GR81821B (enrdf_load_stackoverflow) | 1984-12-12 |
| ATE20879T1 (de) | 1986-08-15 |
| KR840009078A (ko) | 1984-12-24 |
| PT78238A (fr) | 1984-04-01 |
| DK117484A (da) | 1984-09-15 |
| PH19184A (en) | 1986-01-23 |
| KR910002945B1 (ko) | 1991-05-11 |
| PT78238B (fr) | 1986-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4177290A (en) | Acetamide derivatives | |
| US4065584A (en) | Sulphur containing arylamine derivatives | |
| IE57094B1 (en) | 1-(2-carbethoxy 4-benzalkylamido phenoxy)3-amino 2-propanols,preparation thereof and use thereof in therapeutics | |
| JPH04264078A (ja) | ピペラジン誘導体の製造方法 | |
| FI69299C (fi) | Saosom mellanprodukter vid framstaellning av 9-aminoalkyl-9-aminokarbonylfluorenderivat anvaendbara 9-aminoalkyl-9-cyanfluorener | |
| DK147640B (da) | Fremgangsmaade til fremstilling af nitroimidazol-derivater | |
| FI59086C (fi) | Foerfarande foer framstaellning av 2,5-disubstituerade bensamider | |
| US3692784A (en) | N-(phenylalkyl)-acylamide derivatives | |
| US3905968A (en) | Preparation of 1,2-dichloro-3-amino propane derivatives | |
| AU597159B2 (en) | Process for the preparation of nitroethene derivatives | |
| FI64145B (fi) | Foerfarande foer framstaellning av 2-arylamino-2-imidazolinderivat | |
| IE43375B1 (en) | Substituted benzamides, their preparation, and compositions containing them | |
| US6002002A (en) | Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions | |
| EP0294615B1 (en) | Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists | |
| IE32360B1 (en) | Thioimidate intermediates | |
| US4420482A (en) | 1,4-Bis(acetylsalicyloyloxy)piperizine derivatives | |
| CA1276639C (en) | Aminobenzamide derivatives | |
| US4483983A (en) | Substituted derivatives of thiamorpholinone | |
| Konishi | Studies on Organic Insecticides: Part XIII. Synthesis of Nereistoxin and Related Compounds VI | |
| US3873530A (en) | Novel immonium salts | |
| GB2160198A (en) | Imidazolidines | |
| US3539612A (en) | Basic esters of n-phenalkyldithiocarbamic acids | |
| US5849725A (en) | Phosphorylated derivatives of compositions having anti-inflammatory or analgesic activity and a method for the preparation thereof | |
| US4031094A (en) | N-meta-trifluoromethylpiperazines | |
| US4668801A (en) | 1-(2-carboalkoxy 4-(thienyl-alkyl-amido) phenyoxyl 30 amino 20 propanols, their preparation and applications thereof in therapeutics |